Skip to Content

GSI 9883 (Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg)

Generic Name: bictegravir/emtricitabine/tenofovir alafenamide

Pill with imprint GSI 9883 is Brown, Capsule-shape and has been identified as Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc..

Biktarvy is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 9883

Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883
Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883
Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883

Biktarvy

Generic Name:
bictegravir/emtricitabine/tenofovir alafenamide
Imprint:
GSI 9883
Strength:
bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-2501

Get help with Imprint Code FAQs.

More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)

Consumer resources

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide